Literature DB >> 11132948

Ziracin, a novel oligosaccharide antibiotic.

A K Ganguly1.   

Abstract

Ziracin is produced by Micromonospora carbonacea and is highly active against Gram-positive bacteria. In particular it is highly active against methicillin resistant staphylococci and vancomycin resistant enterococci. Ziracin, C71H97NO38Cl2, contains two orthoester linkages, a nitro sugar, a methylene dioxy group, two aromatic ester residues and thirty five centres of assymmetries. In this paper a brief description of the structural elucidation of ziracin is presented along with the chemical modification of the antibiotic which has led to the identification of several potent antibacterials.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11132948     DOI: 10.7164/antibiotics.53.1038

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

1.  Structure and mechanism of ORF36, an amino sugar oxidizing enzyme in everninomicin biosynthesis .

Authors:  Jessica L Vey; Ahmad Al-Mestarihi; Yunfeng Hu; Michael A Funk; Brian O Bachmann; T M Iverson
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

Review 2.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

3.  The Structure of the Bifunctional Everninomicin Biosynthetic Enzyme EvdMO1 Suggests Independent Activity of the Fused Methyltransferase-Oxidase Domains.

Authors:  C A Starbird; Nicole A Perry; Qiuyan Chen; Sandra Berndt; Izumi Yamakawa; Lioudmila V Loukachevitch; Emilianne M Limbrick; Brian O Bachmann; T M Iverson; Kathryn M McCulloch
Journal:  Biochemistry       Date:  2018-12-07       Impact factor: 3.162

4.  Effects of SCH27899 (Ziracin), an oligosaccharide everninomicin antibiotic, on urate kinetics in humans.

Authors:  Satoru Nagashima; Masayuki Niwa; Katsuyuki Nishiki; Tatsuo Hosoya; Akira Hishida; Toshihiko Uematsu
Journal:  Eur J Clin Pharmacol       Date:  2004-04-16       Impact factor: 2.953

5.  Structures of the orthosomycin antibiotics avilamycin and evernimicin in complex with the bacterial 70S ribosome.

Authors:  Stefan Arenz; Manuel F Juette; Michael Graf; Fabian Nguyen; Paul Huter; Yury S Polikanov; Scott C Blanchard; Daniel N Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-21       Impact factor: 11.205

Review 6.  Bioactive oligosaccharide natural products.

Authors:  Emilianne K McCranie; Brian O Bachmann
Journal:  Nat Prod Rep       Date:  2014-08       Impact factor: 13.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.